WHITE RIVER JUNCTION, Vt., Nov. 18, 2025 /PRNewswire/ -- QUEL Imaging, a leader in biomedical optical characterization tools and services, and the Institut National d'Optique (INO), Canada's premier ...

Inovio Pharmaceuticals (INO) reported a disappointing 3Q25 with a GAAP EPS loss of -$0.87, missing consensus by $0.45 and ...

Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday’s session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses. See the ...

Inovio Pharmaceuticals (NASDAQ:INO) had a slight setback with its timeline on when it could actually file its Biologics License Application [BLA] of INO-3107 for the treatment of patients with ...

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, toda ...

Q3 2025 Management View CEO Jacqueline Shea highlighted, “we have achieved our primary objective for this year, which is completing the rolling submission of our BLA for INO-3107. This represents a ...

Inovio (INO) announced data from a retrospective trial showing that the number of Recurrent Respiratory Papillomatosis , or RRP, patients meeting the criteria for a Complete Response, or CR, increased ...

Shares of Inovio Pharmaceuticals INO jumped 20.6% on Wednesday after the FDA agreed to the company’s rolling submission timeline for the biologics license application (BLA) seeking approval for ...

Inovio Pharmaceuticals Inc (NASDAQ:INO) shares are trading lower by 40% to $2.23 during Friday’s session after the company priced a public offering of 10 million shares of common stock and ...